Colorectal
MULTI-001 Nivolumab v11
MULTI-003 Pembrolizumab v12
MULTI-014 Irinotecan & Capecitabine v1
MULTI-018 Larotrectinib v2
MULTI-019 Entrectinib v2
MULTI-022 Ipilimumab in combination with Nivolumab for CRC and RCC v3
MULTI-026 Trifluridine & Tipiracil (Lonsurf®) v2
MULTI-028 Regorafenib v2
MULTI-032 OXALIPLATIN & MOD de GRAMONT v1
MULTI-033 Capecitabine v1
COL-016 Irinotecan & MOD de GRAMONT v5
COL-030 Folfoxiri v2
COL-032 Capecitabine & oxaliplatin plus cetuximab v4
COL-033 Oxaliplatin, Mod de Gramont and Cetuximab v2
COL-041 Encorafenib and cetuximab v3
COL-042 Cetuximab in combination with FOLFOXIRI v1
COL-043 Panitumumab in combination with FOLFOXIRI v2
COL-044 Trifluridine tipiracil with bevacizumab v1
MULTI-003 Pembrolizumab v12
MULTI-014 Irinotecan & Capecitabine v1
MULTI-018 Larotrectinib v2
MULTI-019 Entrectinib v2
MULTI-022 Ipilimumab in combination with Nivolumab for CRC and RCC v3
MULTI-026 Trifluridine & Tipiracil (Lonsurf®) v2
MULTI-028 Regorafenib v2
MULTI-032 OXALIPLATIN & MOD de GRAMONT v1
MULTI-033 Capecitabine v1
COL-030 Folfoxiri v2
COL-032 Capecitabine & oxaliplatin plus cetuximab v4
COL-033 Oxaliplatin, Mod de Gramont and Cetuximab v2
COL-041 Encorafenib and cetuximab v3
COL-042 Cetuximab in combination with FOLFOXIRI v1
COL-043 Panitumumab in combination with FOLFOXIRI v2
COL-044 Trifluridine tipiracil with bevacizumab v1